ASP Isotopes Inc.ASPIEarnings & Financial Report
Nasdaq · Materials · Miscellaneous Chemical Products
ASP Isotopes Inc. is a specialty materials firm focused on developing and producing high-purity custom isotopes. Its products serve key sectors including nuclear medicine, targeted cancer therapies, advanced energy, and industrial research, with customers across North America, Europe and Asia Pacific.
ASPI Q4 FY2025 Key Financial Metrics
Revenue
$16.7M
Gross Profit
$2.1M
Operating Profit
N/A
Net Profit
N/A
Gross Margin
12.5%
Operating Margin
N/A
Net Margin
N/A
YoY Growth
1295.7%
ASP Isotopes Inc. Q4 FY2025 Financial Summary
ASP Isotopes Inc. reported revenue of $16.7M (up 1295.7% YoY) for Q4 FY2025, with a net profit of N/A (down 586.8% YoY) (N/A margin). Cost of goods sold was $14.6M.
Key Financial Metrics
| Total Revenue | $16.7M |
|---|---|
| Net Profit | N/A |
| Gross Margin | 12.5% |
| Operating Margin | N/A |
| Report Period | Q4 FY2025 |
ASP Isotopes Inc. Quarterly Revenue & Net Profit History
ASP Isotopes Inc. results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $16.7M | +1295.7% | N/A | N/A |
| Q3 FY2025 | $4.9M | +349.5% | $-12.9M | -263.7% |
Income Statement
| Q3 2025 | Q4 2025 | |
|---|---|---|
| Revenue | $4.9M | $16.7M |
| YoY Growth | 349.5% | 1295.7% |
Balance Sheet
| Q3 2025 | Q4 2025 | |
|---|---|---|
| Assets | $225.9M | $498.0M |
| Liabilities | $129.3M | $235.1M |
| Equity | $74.1M | $204.2M |
Cash Flow
| Q3 2025 | Q4 2025 | |
|---|---|---|
| Operating CF | $-8.9M | $-37.8M |